Dermatology
Dermatology
Advertisement
Leah LawrenceDermatology | July 21, 2025
Currently approved medications for moderate to severe hidradenitis suppurativa show good efficacy and safety.
Leslie FeldmanMelanoma | July 16, 2025
Mole count and genetics strongly impact mole-linked melanoma risk, while sun exposure affects both melanoma types equally.
Leslie FeldmanPulmonology | July 16, 2025
Living near green spaces may lower asthma risk prenatally but raise it in childhood, with mixed effects on allergies.
Leah LawrenceDermatology | July 3, 2025
TikTok skin care trends for kids may promote costly, irritating routines with little sun protection, researchers warn.
Damiana Chiavolini, PhDDermatology | July 2, 2025
Ucenprubart, a CD200R antibody, shows early promise for safely reducing inflammation in atopic dermatitis, per new study.
Damiana Chiavolini, PhDDermatology | July 2, 2025
JAK inhibitors show promise for vitiligo treatment, improving skin repigmentation with a favorable safety profile.
DocWire News EditorsDermatology | July 1, 2025
The approval was supported by results from the pivotal ADEPT phase 2/3 trial, which assessed for safety and efficacy.
Rob DillardDermatology | June 30, 2025
Pollution and climate extremes may raise atopic dermatitis risk in adults.
Izzah NawazDermatology | June 26, 2025
New research links ATP signaling to immune response in melanoma, helping predict which patients respond to immunotherapy.
Jordana JampelDermatology | June 25, 2025
Elevated risk for psoriasis was consistent across atopic dermatitis subgroups, including those without atopic comorbidities.
Jordana JampelDermatology | June 20, 2025
The protective effect of dog exposure early in life was seen in both cohort groups.
Jordana JampelPsoriasis | June 17, 2025
Adiposity may influence psoriasis through mechanisms separate from known genetic pathways.
Leah LawrenceDermatology | June 16, 2025
Neurosteroids may play a central role in itch linked to atopic dermatitis.
Izzah NawazDermatology | June 11, 2025
Tiny particles in cow colostrum reduced eczema symptoms in mice, pointing to a potential new natural therapy.
Leah LawrenceDermatology | June 4, 2025
AI model uses smartphone images to objectively track eczema severity.
Nsisong Asanga, PhDDermatology | May 29, 2025
Phase 3 trial shows ivarmacitinib is effective and safe for moderate to severe atopic dermatitis in teens and adults.
Jordana JampelASCO 2025 | May 28, 2025
Researchers identified the pathologic and clinical characteristics of patients who experience disease relapse.
Izzah NawazDermatology | May 27, 2025
Study finds early lebrikizumab response in AD linked to lower inflammation—may guide personalized treatment plans.
Jordana JampelDermatology | May 23, 2025
Treatment with the drug demonstrated lesion and pain control in moderate to severe disease.
Jordana JampelDermatology | May 22, 2025
Symptomatic benefits of treatment on the severity of pustules, erythema, and scaling were observed.
Advertisement